Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $34.16 USD
Change Today -0.14 / -0.41%
Volume 24.8M
PFE On Other Exchanges
New York
Sao Paulo
As of 8:04 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mikael Dolsten Ph.D.

President of Worldwide Research and Development, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Prof. Mikael Dolste, Ph.D. has been the President of Worldwide Research and Development at Pfizer Inc. since December 2010. Prof. Dolsten serves as Head of Corporate Division Pharma Research/Discovery at Boehringer Ingelheim with responsibility for approximately 1400 discovery scientists and world-wide research in respiratory, immunology/inflammation, metabolic disease, CNS/pain, oncology and cardiovascular therapies. Prof. Dolsten has spent approximately seventeen years ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Former Director


Unknown/Other Education
Weizmann Institute Of Science
Lund University
Lund University
Skåne University Hospital

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,177,500

Stock Options*

Restricted Stock Awards$1,863,860
All Other Compensation$156,180
Exercisable Options530,757
Exercisable Options Value$6,678,912
Unexercisable Options1,051,432
Unexercisable Options Value$5,456,034
Total Value of Options$12,134,946
Total Number of Options1,582,189

Total Compensation*

Total Annual Cash Compensation$2,633,680
Total Short Term Compensation$1,177,500
Other Long Term Compensation$2,020,040
Total Calculated Compensation$7,275,054
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $34.16 USD -0.14


Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Joseph Jimenez MBAChief Executive Officer
Novartis AG
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at